Shanghai Tianci Biovalley Bioengineering Co., Ltd.

The company is headquartered in Zhangjiang, Shanghai, and is an international high-tech new drug R&D company. Its management, R&D, and advisory teams are composed of senior experts and scholars with extensive industry experience. The company has over 5,000 square meters of R&D centers in Zhangjiang, Shanghai and Wujiang, Jiangsu, equipped with first-class professional instruments and equipment (including a pilot plant built to GMP requirements). It is currently constructing six new GMP workshops for API production in Anhui that meet international standards, to meet the requirements for drug R&D and industrialization. The company has a professional pharmaceutical sales team of 4,000 people, with strong drug marketing capabilities.
The company has over ten years of new drug development experience, with leading R&D capabilities nationwide. For years, it has provided technology transfer to leading domestic enterprises such as China National Pharmaceutical Group, Shanghai Pharmaceutical, and China Resources, especially having unique advantages in the field of drug registration. It provides professional CRO technical services for drugs, including: new drug development, sample customization (including pilot scale), quality evaluation, impurity research, process optimization, and technical consultation.
The company upholds the corporate culture of "Use it here, leave it here; everything in the world is for your use but not your possession," continuously dedicating more human, material, and financial resources to R&D and innovation. The company's purpose is the "Three For": to make a modest contribution to human health through continuous research and exploration, making life more powerful; to fulfill social responsibility for social harmony and for ordinary people to have access to effective, low-cost, and safe medicines; and to contribute to the enhancement of China's high-tech innovation status and the global influence of intellectual property. Shanghai Tianci Biovalley Bioengineering Co., Ltd. will forge ahead, break the passive situation where China only exports APIs, lead China's original drugs to the world, and bring good news to humanity.

Honors obtained:
2012 Chinese Pharmaceutical Association Science and Technology Award
2013 China Industry-University-Research Cooperation Innovation Achievement Award
High-Tech Enterprise Certification

National/Local science and technology projects undertaken:
"Major New Drug Creation" National Science and Technology Major Project
Shanghai Science and Technology Commission Biomedical Field Science and Technology Support Plan
Shanghai Science and Technology Commission Biomedical Field Industry-University-Research Cooperation Project
Shanghai SME Innovation Fund
:*